Neuropsychopharmacology
- Sensorimotor circuit connectivity as a candidate biomarker for responsiveness to sertraline in obsessive–compulsive disorder5 months ago
- Transcriptional profiles of antidepressant resistance across the corticolimbic pathway of chronically stressed mice5 months ago
- Task-guided accelerated cTBS simultaneously treats depression and social dysfunction in patients with major depressive disorder: a randomized clinical trial5 months ago
- Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine5 months ago
- Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence5 months ago
- Disinhibition of ventral tegmental area during initial punishment learning causes enduring punishment insensitivity5 months ago
- The puzzle of heterogeneity: an introduction to part II5 months ago
Journal of Psychopharmacology
- The effects of lithium on cognition in humans: A systematic review9 months ago
- Effects of electroconvulsive shock on astroglial reactivity in a rat model of antipsychotic-induced neurotoxicity9 months ago
- Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs9 months ago
- A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer9 months ago
- β-blockers’ neuropsychiatric risks: Overlooked evidence?10 months ago
- Efficacy and adverse effect profile of vortioxetine in major depressive disorder: A meta-analysis10 months ago
- Monoamine oxidase inhibitors: A paradigm of poor science10 months ago
European Neuropsychopharmacology
- Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigations11 months ago
- Methodological gaps in treatment-resistant depression prediction11 months ago
- Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis11 months ago
- Antipsychotic polypharmacy in patients with schizophrenia between 1999 and 2024 in Denmark: Prevalence, time trends, and combinations11 months ago
- Letter to “Differences in resting-state functional connectivity between depressed bipolar and major depressive disorder patients: A machine learning study”11 months ago
- Letter to the Editor: On clinical predictors of treatment-resistant depression: Comments on validation strategy, predictor independence, and clinical implementation11 months ago
- Strategies for improving research on semaglutide in cocaine use disorder11 months ago